Moderate

Long-term oxygen therapy & oxygen assessment

LTOT · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Long-term oxygen therapy improves survival in chronic hypoxaemic respiratory failure (most evidence in COPD) when used >=15 hours/day. Careful assessment of resting arterial oxygenation during a stable period is required, as oxygen for mild/exertional-only desaturation does not improve survival.

Red flags

  • Continued smoking (fire and burn risk)
  • Rising CO2 / respiratory acidosis on oxygen
  • Decompensated cor pulmonale
  • Worsening hypoxaemia despite therapy

Assessment

Differential diagnosis

  • COPD with chronic hypoxaemia
  • Interstitial lung disease
  • Pulmonary hypertension
  • Chronic heart failure
  • Chest-wall/neuromuscular disease

Investigations

  • Arterial blood gases on air when clinically stable (repeated to confirm)
  • Oximetry at rest and on exertion
  • Assessment for hypercapnia and risk of CO2 retention
  • Carboxyhaemoglobin (confirm smoking cessation and fire-risk safety)
  • Echocardiography for cor pulmonale; full disease assessment

Management

  • Ensure the patient is clinically stable for >=8 weeks and on optimal therapy before assessing
  • Measure resting arterial blood gases on air (confirm with a repeat)
  • Qualify for LTOT if PaO2 <=7.3 kPa, or <=8.0 kPa with cor pulmonale/polycythaemia/nocturnal hypoxaemia
  • Assess for hypercapnia and titrate oxygen to a safe target saturation
  • Confirm the patient does not smoke and counsel on fire and burn risk
  • Prescribe concentrator oxygen for >=15 hours per day
  • Arrange ambulatory oxygen only where it corrects exertional desaturation and improves exercise
  • Do not prescribe oxygen for breathlessness without hypoxaemia
  • Provide safety education and home-fire-risk assessment
  • Review blood gases after initiation and reassess regularly

Drugs & doses

Oxygen via concentrator titrated to target SpO2 (e.g. 90-92% in those at risk of retention)
Ambulatory oxygen for exertional desaturation where benefit demonstrated
Optimise bronchodilators and treat the underlying disease
Smoking-cessation pharmacotherapy (oxygen is contraindicated in continuing smokers due to fire risk)

Disposition

Home oxygen assessment service; respiratory follow-up with repeat gases; fire-safety assessment.

Complications & pitfalls

  • Burns/fire from smoking on oxygen
  • CO2 retention and acidosis
  • Dependence and reduced mobility
  • Nasal mucosal drying and discomfort

Exam pearls

  • Oxygen improves survival only in chronic resting hypoxaemia used >=15 h/day, not for isolated exertional desaturation
  • Never prescribe home oxygen to a current smoker due to fire risk
  • Assess during clinical stability, not during or soon after an exacerbation
  • Breathlessness without hypoxaemia is not an indication for oxygen — consider other measures

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.